Evidence map›Paper›PMID 41401975›Full record

ArticleChemMedChem2026

A Facile Protocol for C(sp

Anita Maksutova, Thomas M Geiger, Lorenzo Cianni, Dominika E Pieńkowska, Jan Gerhartz, Lina Read, Aleša Bricelj, Alexander Herrmann, Maurice Leon Nelles, Yuen Lam Dora Ng and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A Facile Protocol for C(spChemMedChem · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anita MaksutovaPharmaceutical Institute, University of Bonn, An der Immenburg 4, DE-53121, Bonn, Germany.
Thomas M GeigerInstitute of Structural Biology, University of Bonn, Venusberg-Campus 1, DE-53127, Bonn, Germany.ORCID https://orcid.org/0000-0002-6278-3990
Lorenzo CianniInstitute of Structural Biology, University of Bonn, Venusberg-Campus 1, DE-53127, Bonn, Germany.ORCID https://orcid.org/0000-0002-3668-9554
Dominika E PieńkowskaInstitute of Structural Biology, University of Bonn, Venusberg-Campus 1, DE-53127, Bonn, Germany.
Jan GerhartzInstitute of Structural Biology, University of Bonn, Venusberg-Campus 1, DE-53127, Bonn, Germany.ORCID https://orcid.org/0009-0002-9457-4656
Lina ReadInstitute of Structural Biology, University of Bonn, Venusberg-Campus 1, DE-53127, Bonn, Germany.
Aleša BriceljFaculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, SI-1000, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-8090-4477
Alexander HerrmannMax Planck Institute for Biology, Max-Planck-Ring 1, DE-72076, Tübingen, Germany.ORCID https://orcid.org/0000-0002-4241-942X
Maurice Leon NellesPharmaceutical Institute, University of Bonn, An der Immenburg 4, DE-53121, Bonn, Germany.ORCID https://orcid.org/0009-0006-5326-6971
Yuen Lam Dora NgDepartment of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, DE-12203, Berlin, Germany.ORCID https://orcid.org/0000-0001-7959-454X
Marcus D HartmannMax Planck Institute for Biology, Max-Planck-Ring 1, DE-72076, Tübingen, Germany.ORCID https://orcid.org/0000-0001-6937-5677
Jan KrönkeDepartment of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, DE-12203, Berlin, Germany.ORCID https://orcid.org/0000-0002-4649-0506
Izidor SosičFaculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, SI-1000, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-3370-4587
Radosław P NowakInstitute of Structural Biology, University of Bonn, Venusberg-Campus 1, DE-53127, Bonn, Germany.ORCID https://orcid.org/0000-0002-0605-0071
Michael GütschowPharmaceutical Institute, University of Bonn, An der Immenburg 4, DE-53121, Bonn, Germany.ORCID https://orcid.org/0000-0002-9376-7897
Christian SteinebachPharmaceutical Institute, University of Bonn, An der Immenburg 4, DE-53121, Bonn, Germany.ORCID https://orcid.org/0000-0001-5638-1955

Funding

Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) 494832089Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) 507275896Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) 552374678
6 · The paper itself

Abstract

A straightforward method for creating C(sp

Indexed as

Ubiquitin-Protein LigasesAdaptor Proteins, Signal TransducingBromodomain Containing ProteinsCell Cycle ProteinsHumansLigandsMolecular StructurePhthalimidesProteolysisStructure-Activity RelationshipTranscription FactorsAdaptor Proteins, Signal TransducingBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsCRBN protein, humanLigandsPhthalimidesTranscription FactorsUbiquitin-Protein LigasescereblonC(sp2)–C(sp3) bond formationE3 ligandsmedicinal chemistryproteolysis‐targeting chimeras

Identifiers

PMID41401975
PMCPMC12913232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.